No Data
Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the
① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.
Beijing Centergate Technologies (000931.SZ): Its subsidiary, Zhongshi New Materials, has once again received the high-tech enterprise certification.
On February 20, Gelonghui reported that Beijing Centergate Technologies (000931.SZ) announced that its subsidiary, Beijing Zhongshi Concrete Co., Ltd., received the "High-tech Enterprise Certificate" issued jointly by the Beijing Science and Technology Commission, Beijing Finance Bureau, and the State Administration of Taxation Beijing Taxation Bureau. The certificate number is GR202411008417, issued on December 31, 2024, with a validity period of three years. Zhongshi New Materials has again obtained the qualification of a high-tech enterprise, which is beneficial for enhancing the company's core competitiveness.
Beijing Centergate Technologies (000931.SZ): Lin Feiyan cancels the concerted action relationship with Gome Holdings and Gome Electrical Appliances.
On February 14th, Gelonghui reported that Beijing Centergate Technologies (000931.SZ) announced that it recently received the "Agreement on Termination of Joint Action Relationship" signed by the company's controlling Shareholder Gome Holdings Group Co., Ltd. (referred to as: Gome Holdings) and its concerted actor Gome Electrical Appliances Co., Ltd. (referred to as: Gome Electrical Appliances) with Lin Feiyan, terminating the joint action relationship between Lin Feiyan, Gome Holdings, and Gome Electrical Appliances.
Beijing Centergate Technologies (000931.SZ): Subsidiary company Beijing Huasu Pharmaceutical has changed its production license and passed the Pharmaceutical GMP compliance inspection.
On February 14, Glonghui reported that Beijing Centergate Technologies (000931.SZ) announced that its subsidiary, Beijing Huasu Pharmaceutical Co., Ltd. (shortened as: Beijing Huasu), has obtained the "Approval Notification for the Listing Application of Chemical Raw Materials" issued by the National Medical Products Administration. Beijing Huasu has received the "Pharmaceutical Production License" (License No: Jing 20150168) issued by the Beijing Medical Products Administration and the "Pharmaceutical GMP Compliance Inspection Notice" (No: Jing Yao Jian Yao GMP [2024] 020069). The change in the "Pharmaceutical Production License" involves the Lingang area of Cangzhou, Hebei Province.
Beijing Centergate Technologies (000931.SZ) subsidiary company Schisandra Injection has been selected for the national Chinese Patent Medicine procurement alliance centralized procurement.
Beijing Centergate Technologies (000931.SZ) announced that its subsidiary, Duoduo Pharmaceutical Co., Ltd. (abbreviated as: Duoduo Pharmaceutical) participates...
Beijing Centergate Technologies (000931.SZ): The application for the consistency evaluation of tramadol hydrochloride tablets (specification: 50mg) has been accepted.
Beijing Centergate Technologies (000931.SZ) issued an announcement that its subsidiary, Peking Huasu Pharmaceutical Co., Ltd. (hereinafter referred to as...